Neurotransmitter Receptor Systems Archives - Page 2 of 3

The Neurobiology Of Opioids

Video June 10, 2019

Hear from Chip Meyer, Ph.D., a Medical Science Liaison with Otsuka Pharmaceutical Development & Commercialization, Inc., as he examines the historic medical utilization and underlying neurobiological mechanisms of opioids. Explore… Read More

The Role Of Glutamate In Mood Disorders & Schizophrenia

On-Demand Webinar March 19, 2019

Glutamate is the predominant excitatory neurotransmitter in the nervous system, and glutamatergic dysregulation has been implicated in the pathophysiology of both mood disorders and schizophrenia. In this webinar, Dr. James… Read More

Webinar Summary – Gender Differences In Depression

Article March 7, 2019

This summary was developed utilizing the full recorded presentation of this webinar. You can access the full sourcing, polling results, recording, or presentation slides here: https://psychu.org/gender-differences-in-depression/. On March 7, 2019,… Read More

Evolving Pharmacology Of Depression: Beyond The Monoamine Hypothesis

On-Demand Webinar October 9, 2018

According to the World Health Organization, major depressive disorder (MDD) currently impacts 300 million individuals worldwide and is the leading cause of disability globally. Current treatment strategies for depression are… Read More

Webinar Summary – Evolving Psychopharmacology Of Depression: Beyond The Monoamine Hypothesis

Article October 9, 2018

This summary was developed utilizing the full recorded presentation of this webinar. You can access the full sourcing, polling results, recording, or presentation slides here: https://psychu.org/evolving-pharmacology-depression-beyond-monoamine-hypothesis/. On October 9, 2018,… Read More

Neuromodulation Techniques: State Of The Science

On-Demand Webinar July 11, 2018

Clinicians managing patients with behavioral health issues are presented with various diagnostic and treatment challenges, spanning the areas of neurobiology, adherence, safety, and medication tolerability. Currently available pharmacotherapeutic, psychotherapeutic, and… Read More

Webinar Summary – The Evolution Of Post-Traumatic Stress Disorder: Focus On Diagnostic, Evaluation, & Treatment Advances

Article June 27, 2018

This summary was developed utilizing the full recorded presentation of this webinar, which is available on PsychU for all members free of charge. For full sourcing and polling results, please… Read More

The Evolution Of Post-Traumatic Stress Disorder: Focus On Diagnostic, Evaluation, & Treatment Advances

On-Demand Webinar June 27, 2018

During this webinar William Sauvé, MD, Regional Medical Director at Greenbrook TMS Neurohealth in Glen Allen, Virginia and Steven Szabo, MD, PhD Assistant Professor of Psychiatry and Behavioral Sciences at… Read More

Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, & Therapy

Article March 28, 2018

Key Messages First-generation antipsychotics (FGAs) and second-generation antipsychotics (SGAs) provided major therapeutic advances for idiopathic and non-idiopathic psychotic disorders, but long-term D2 receptor blockade by these medications can lead to… Read More

Genetic Variation & The D2 Dopamine Receptor: Implications For The Treatment Of Neuropsychiatric Disease

Article September 14, 2017

Key Messages This editorial examined genetic variation in the D2 dopamine receptor system and the implications for treatment of neuropsychiatric disease. The most commonly studied variant in published in vivo… Read More

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: